PremiumCompany AnnouncementsCSPC’s Efmedaglutide Shows Strong Phase III Results Against Dulaglutide in Chinese Diabetes Trial7d ago
PremiumCompany AnnouncementsCSPC Wins U.S. FDA Nod for Clinical Trials of Recombinant Shingles Vaccine8d ago